AdvaMed® Q2 2026: Progress for Patients and the Medtech Community
The second quarter of 2026 marked significant progress for the medtech industry despite a challenging policy environment. We reached agreement with the FDA on the MDUFA VI commitment letter, continued advancing a timely and predictable Medicare coverage pathway for breakthrough technologies through the RAPID framework, and drove meaningful progress on digital health, data, artificial intelligence (AI), cybersecurity, coding, and payment policy.
Q2 also demonstrated the power of member engagement. AdvaMed’s Board meetings and Capitol Hill fly-in brought industry leaders together with policymakers for important discussions on tariffs, Medicare coverage and payment, FDA policy, diagnostics, medical imaging, and global affairs, strengthening our collective voice on the issues shaping the future of medtech.
From advancing regulatory certainty to expanding patient access through innovative coverage policies, AdvaMed continues to advocate for solutions that support innovation and improve patient care. Download the full Q2 2026 Report to learn how AdvaMed’s initiatives are driving meaningful results for the medtech industry.